Ehsan Sharif‐Askari

449 total citations
8 papers, 372 citations indexed

About

Ehsan Sharif‐Askari is a scholar working on Immunology, Molecular Biology and Epidemiology. According to data from OpenAlex, Ehsan Sharif‐Askari has authored 8 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 3 papers in Molecular Biology and 3 papers in Epidemiology. Recurrent topics in Ehsan Sharif‐Askari's work include Immune Cell Function and Interaction (3 papers), interferon and immune responses (2 papers) and T-cell and Retrovirus Studies (2 papers). Ehsan Sharif‐Askari is often cited by papers focused on Immune Cell Function and Interaction (3 papers), interferon and immune responses (2 papers) and T-cell and Retrovirus Studies (2 papers). Ehsan Sharif‐Askari collaborates with scholars based in Canada, Martinique and Lebanon. Ehsan Sharif‐Askari's co-authors include Lama Fawaz, José Menézes, Ali Ahmad, Luchino Y. Cohen, Antoine Alam, Rafick‐Pierre Sékaly, Elias K. Haddad, Juscilene S. Menezes, Phuoc T. Tran and John C. Bell and has published in prestigious journals such as The EMBO Journal, The Journal of Immunology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Ehsan Sharif‐Askari

8 papers receiving 368 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ehsan Sharif‐Askari Canada 7 207 148 121 59 54 8 372
Luciana Poddighe Italy 5 119 0.6× 158 1.1× 69 0.6× 57 1.0× 41 0.8× 6 393
Marjory Desmedt Belgium 7 227 1.1× 149 1.0× 61 0.5× 57 1.0× 19 0.4× 9 411
Hajime Komano Japan 7 264 1.3× 142 1.0× 48 0.4× 44 0.7× 52 1.0× 10 447
Claudia Gürtler Ireland 5 226 1.1× 194 1.3× 54 0.4× 37 0.6× 20 0.4× 6 368
Jenny M. McLaughlan United Kingdom 5 77 0.4× 171 1.2× 120 1.0× 38 0.6× 68 1.3× 6 341
Caroline R. Boyd United Kingdom 5 215 1.0× 108 0.7× 115 1.0× 61 1.0× 12 0.2× 6 337
Madhuvanthi Vijayan United States 12 219 1.1× 262 1.8× 126 1.0× 28 0.5× 35 0.6× 14 415
Yoshiko Kobune Japan 6 111 0.5× 138 0.9× 59 0.5× 49 0.8× 20 0.4× 6 357
Uma Sinha-Datta United States 9 310 1.5× 130 0.9× 34 0.3× 28 0.5× 36 0.7× 11 440
Suk Min Jang Switzerland 12 75 0.4× 454 3.1× 92 0.8× 47 0.8× 58 1.1× 15 595

Countries citing papers authored by Ehsan Sharif‐Askari

Since Specialization
Citations

This map shows the geographic impact of Ehsan Sharif‐Askari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ehsan Sharif‐Askari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ehsan Sharif‐Askari more than expected).

Fields of papers citing papers by Ehsan Sharif‐Askari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ehsan Sharif‐Askari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ehsan Sharif‐Askari. The network helps show where Ehsan Sharif‐Askari may publish in the future.

Co-authorship network of co-authors of Ehsan Sharif‐Askari

This figure shows the co-authorship network connecting the top 25 collaborators of Ehsan Sharif‐Askari. A scholar is included among the top collaborators of Ehsan Sharif‐Askari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ehsan Sharif‐Askari. Ehsan Sharif‐Askari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
2.
Lin, Rongcheng, Peyman Nakhaei, Lili Yang, et al.. (2006). Negative regulation of the RIG-I induced antiviral state by the ubiquitin editing protein A20. STM:n Hallinnonalan avoin julkaisuarkisto (Julkari). 1 indexed citations
3.
Césaire, Raymond, Stéphanie Olière, Ehsan Sharif‐Askari, et al.. (2005). Oncolytic activity of vesicular stomatitis virus in primary adult T-cell leukemia. Oncogene. 25(3). 349–358. 25 indexed citations
5.
Sharif‐Askari, Ehsan. (2001). Direct cleavage of the human DNA fragmentation factor-45 by granzyme B induces caspase-activated DNase release and DNA fragmentation. The EMBO Journal. 20(12). 3101–3113. 111 indexed citations
6.
Sharif‐Askari, Ehsan, Lama Fawaz, Phuoc T. Tran, Ali Ahmad, & Juscilene S. Menezes. (2001). Interleukin 15-Mediated Induction of Cytotoxic Effector Cells Capable of Eliminating Epstein-Barr Virus-Transformed/Immortalized Lymphocytes in Culture. JNCI Journal of the National Cancer Institute. 93(22). 1724–1732. 22 indexed citations
7.
Ahmad, Ali, Ehsan Sharif‐Askari, Lama Fawaz, & José Menézes. (2000). Innate Immune Response of the Human Host to Exposure with Herpes Simplex Virus Type 1: In Vitro Control of the Virus Infection by Enhanced Natural Killer Activity via Interleukin-15 Induction. Journal of Virology. 74(16). 7196–7203. 61 indexed citations
8.
Fawaz, Lama, Ehsan Sharif‐Askari, & José Menézes. (1999). Up-Regulation of NK Cytotoxic Activity Via IL-15 Induction by Different Viruses: A Comparative Study. The Journal of Immunology. 163(8). 4473–4480. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026